“The sudden increase in demand for medical products to address the COVID-19 pandemic has led to an expansion in the trafficking of substandard and falsified products, according to research published today by the United Nations Office on Drugs and Crime (UNODC).

The virus has further highlighted the shortcomings in regulatory and legal frameworks aimed at preventing the manufacture and trafficking of such products, the “COVID-19-related Trafficking of Medical Products as a Threat to Public Health” research brief points out.”

To read the full Research Brief, click here.